Madalina Butnariu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
28
Citations
66
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
This researcher's publication record centers on inflammatory bowel disease (IBD), particularly how it affects women during pregnancy and postpartum, and on optimizing drug treatments such as biologics like adalimumab and infliximab. The work often draws on clinical and real-world patient data, including studies on hospitalization risk, disease flares, medication management, and quality-of-life interventions like exercise programs. Note that the listed OpenAlex topic relevance scores are all zero, so the topic labels provided may not strongly reflect the actual focus, which based on publication titles appears to be clinical gastroenterology and women's health.
Publication output has been modest but fairly steady over the last decade, with a gap in 2017-2018 and 2021, followed by a more consistent output of 2-3 papers per year from 2022 onward.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Exercising Options: Personalized Exercise Program Improves Fatigue and Quality of Life Scores in Patients with Inflammatory Bowel Disease
Digestive Diseases and Sciences · 2025
- S2019 Clinical Predictors of Hospitalizations During Pregnancy in Patients With Inflammatory Bowel Disease
The American Journal of Gastroenterology · 2025
- Impact of Clinical Pharmacists in the Inflammatory Bowel Disease Clinic
Journal of Pharmacy Practice · 2024
- Su1828 PRECISION DOSING TEST FOR OPTIMIZING ADALIMUMAB IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EVIDENCE STUDY
Gastroenterology · 2024
- Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare
Archives of Gynecology and Obstetrics · 2022
- Women’s Health and Ulcerative Colitis
Gastroenterology Clinics of North America · 2020
- Sa1854 WOMEN WITH IMMUNE MEDIATED INFLAMMATORY DISEASES WHO USE BIOLOGICS DURING PREGNANCY HAVE A HIGHER RISK FOR POSTPARTUM FLARE
Gastroenterology · 2020
- Endoscopic Remission After Infliximab Treatment in a Patient with Ipilimumab-Induced Colitis
The American Journal of Gastroenterology · 2016
- The American Journal of Gastroenterology×8
- Gastroenterology×2
- Archives of Gynecology and Obstetrics×1
- Gastroenterology Clinics of North America×1
- Obstetrics and Gynecology×1
- Hilary K. Michel
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Matthew Bohm
Biochemistry, Genetics and Molecular Biology · Indiana University
- Antonia Boger-May
Biochemistry, Genetics and Molecular Biology · Indiana University
- Bin Dong
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Brendan Boyle
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile